Mental and Behavioral Health

New research presented at the 2022 American Psychiatric Association Annual Meeting evaluated program to help address the opioid epidemic.

The approval makes the drug the first novel nonstimulant ADHD therapy approved in the last 20 years.

Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.

Home environments have a clear impact on depression treatment outcomes.

Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.

A recent study found a negative association between children with ADHD and health eating patterns.

The warnings cite consumer risks and Food, Drug and Cosmetics Act violations.

The new drug treats acute agitation associated with schizophrenia, bipolar I, or bipolar II in adults.

Recent research supports evidence for long-term impairment in memory, executive function.

Study shows that people who live in communities with higher levels of racial prejudice have higher rates of heart disease and mental health problems.

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.

Catch up on all the latest in ADHD from the virtual APSARD 2022 Annual Meeting.

Cariprazine is already approved to treat schizophrenia and bipolar I in adults.

Zuranolone treatment in patients with major depressive disorder demonstrates a rapid and statistically significant reduction in depressive symptoms.

A Kaiser Family Foundation survey found that all the responding programs had at least one initiative to expand behavioral health services.

Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).

Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.

Further research is needed to determine causation.

First time outpatient visits for mental health services were sharply increased compared with the period before the pandemic.